Abstract
The application of Health Technology Assessment (HTA) and Pharmacoeconomics (PE) into real health policies in the selected European countries Austria, Bulgaria, Croatia, Czech Republic, Germany, Hungary, Latvia, Poland, Romania, Serbia, Slovakia, Slovenia, UK (Figure 1) was analyzed based on the outputs from the conference „Optimization of PE and HTA: Importance for National Health Policy and Cross-Border Cooperation” (Slovakia,10/2012).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have